Hint mode is switched on Switch off
For swift navigation between sections

PhaseBio Pharmaceuticals
LEI 549300FC27CEJIY52K95

PDF download

Choose all Reset all
Download Cancel
Organization name
PhaseBio Pharmaceuticals, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat orphan diseases with an initial focus on cardiopulmonary indications. The company was founded in 2002 and is based in Malvern, Pennsylvania.

Awards

News

17/11/2023 PhaseBio Pharmaceuticals: Other Events, Financial Statements And Exhibits
27/09/2023 PhaseBio Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
22/09/2023 PhaseBio Pharmaceuticals: Other Events, Financial Statements And Exhibits
24/07/2023 PhaseBio Pharmaceuticals: Other Events, Financial Statements And Exhibits
22/06/2023 PhaseBio Pharmaceuticals: Other Events, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2022
I q eng
II q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300FC27CEJIY52K95
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001169245
Registration is required to get access.